ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

ATOS Company Profile and Key Details

NASDAQ : ATOS

Atossa Therapeutics, Inc.

$0.74

-0.0002-0.03%

At Close 4:00 PM

54.83

B-ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

ATOS Stock Price Chart

Stock Price Today

Atossa Therapeutics, Inc. (ATOS) stock declined over -0.03%, trading at $0.74 on NASDAQ, down from the previous close of $0.74. The stock opened at $0.73, fluctuating between $0.71 and $0.76 in the recent session.

Stock Snapshot

0.741

Prev. Close

0.73

Open

93.19M

Market Cap

125.8M

Number of Shares

0.7067

Day Low

0.7635

Day High

-3.53

P/E Ratio

99.98%

Free Float in %

-0.21

EPS (TTM)

0.73

Book Value

-0.17

Cash Flow per Share

459.78K

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 11, 2025	0.73	0.76	0.71	0.74	465.14K
Mar 10, 2025	0.73	0.75	0.71	0.74	605.63K
Mar 07, 2025	0.77	0.77	0.72	0.74	273.91K
Mar 06, 2025	0.76	0.77	0.73	0.75	397.48K
Mar 05, 2025	0.72	0.76	0.72	0.74	232.2K
Mar 04, 2025	0.73	0.75	0.71	0.73	410.97K
Mar 03, 2025	0.76	0.77	0.73	0.74	717.17K
Feb 28, 2025	0.75	0.77	0.73	0.77	501.93K
Feb 27, 2025	0.77	0.79	0.74	0.75	423.8K
Feb 26, 2025	0.76	0.79	0.76	0.77	397.22K
Feb 25, 2025	0.79	0.80	0.75	0.75	735.68K
Feb 24, 2025	0.80	0.80	0.78	0.78	457.23K
Feb 21, 2025	0.85	0.85	0.79	0.80	566.9K
Feb 20, 2025	0.88	0.88	0.84	0.84	430.03K
Feb 19, 2025	0.86	0.89	0.85	0.88	626.72K
Feb 18, 2025	0.82	0.86	0.82	0.84	591.86K
Feb 14, 2025	0.81	0.85	0.80	0.83	635K
Feb 13, 2025	0.77	0.82	0.77	0.82	622.91K
Feb 12, 2025	0.79	0.80	0.77	0.77	656.09K
Feb 11, 2025	0.82	0.82	0.77	0.78	662.44K

Contact Details

Seattle, WA 98104

United States

Website: https://www.atossatherapeutics.comContact: 206 588 0256

About Company

Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing AT-H201, an inhalation therapy to improve lung function in severely ill and hospitalized COVID-19 patients; AT-301, a proprietary drug candidate for nasal administration in patients diagnosed with COVID-19; and immunotherapy/chimeric antigen receptor therapy programs for the treatment of breast cancer. It has a research agreement with Dana-Farber Cancer Institute, Inc. to support research of cytokine-coated nanoparticles for the treatment of breast cancer. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is headquartered in Seattle, Washington.

Frequently Asked Questions

What is the current Atossa Therapeutics, Inc. (ATOS) stock price?

Atossa Therapeutics, Inc. (NASDAQ: ATOS) stock price is $0.74 in the last trading session. During the trading session, ATOS stock reached the peak price of $0.76 while $0.71 was the lowest point it dropped to. The percentage change in ATOS stock occurred in the recent session was -0.03% while the dollar amount for the price change in ATOS stock was -$0.00.

ATOS's industry and sector of operation?

The NASDAQ listed ATOS is part of Biotechnology industry that operates in the broader Healthcare sector. Atossa Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of ATOS?

Mr. Kyle Guse CPA, CPA, Esq.
Chief Financial Officer, Gen. Counsel & Sec.
Mr. Kyle Guse C.P.A., CPA, Esq.
Chief Financial Officer, Gen. Counsel & Sec.
Mr. Gregory L. Weaver CPA, M.B.A.
Non-Employee Advisor
Ms. Heather Rees
Vice President of Fin. & Accounting
Ms. Delly Behen P.H.R.
Vice President of Admin. & HR
Ms. Janet Rose Rea MSPH, RAC
Senior Vice President of Regulatory, Quality & Clinical Affairs
Mr. Kyle Guse CPA, Esq., CPA
Chief Financial Officer, Gen. Counsel & Sec.
Dr. Richard Graydon M.D., Ph.D.
Interim Chief Medical Officer
Dr. Steven C. Quay FCAP, M.D., Ph.D.
Chairman, Chief Executive Officer & Pres

How ATOS did perform over past 52-week?

ATOS's closing price is 4.83% higher than its 52-week low of $0.71 where as its distance from 52-week high of $2.31 is -67.93%.

How many employees does ATOS have?

Number of ATOS employees currently stands at 12.

Link for ATOS official website?

Official Website of ATOS is: https://www.atossatherapeutics.com

How do I contact ATOS?

ATOS could be contacted at phone 206 588 0256 and can also be accessed through its website. ATOS operates from 107 Spring Street, Seattle, WA 98104, United States.

How many shares of ATOS are traded daily?

ATOS stock volume for the day was 459.78K shares. The average number of ATOS shares traded daily for last 3 months was 752.28K.

What is the market cap of ATOS currently?

The market value of ATOS currently stands at $93.19M with its latest stock price at $0.74 and 125.8M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	12
Beta	1.2
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology